Endotoxin Tolerance Variation over 24 h during Porcine Endotoxemia: Association with Changes in Circulation and Organ Dysfunction

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Castegren, Markus ^a   Skorup, Paul ^a   Lipcsey, Miklós ^a   Larsson, Anders ^a   Sjölin, Jan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ENDOTOXIN; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRATE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ALKALOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE VARIABILITY; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOTOXEMIA; ENDOTOXIN TOLERANCE; EX VIVO STUDY; EXPERIMENTAL PIG; HEART INDEX; HEART LEFT VENTRICLE WORK; HEMOGLOBIN BLOOD LEVEL; LEUKOCYTE COUNT; LUNG COMPLIANCE; MEAN ARTERIAL PRESSURE; MULTIPLE ORGAN FAILURE; NONHUMAN; ORGAN CIRCULATION; OXYGEN CONSUMPTION; PHYSICAL TOLERANCE; PROTEIN BLOOD LEVEL; SYSTEMIC VASCULAR RESISTANCE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; URINARY EXCRETION;

ANIMALS; ARTERIAL PRESSURE; BLOOD CIRCULATION; ENDOTOXEMIA; ENDOTOXINS; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTE COUNT; ORGAN SPECIFICITY; PLATELET COUNT; SUS SCROFA; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR RESISTANCE;

ANIMALIA; SUIDAE; SUS;

EID: 84872237958     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053221     Document Type: Article

References (40)

1. Alexander C, Rietschel ET, (2001) Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7: 167-202.
2. West MA, Heagy W, (2002) Endotoxin tolerance: a review. Crit Care Med 30: S64-73.
3. Cavaillon J-M, Adib-Conquy M, (2006) Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 10: 233 doi:10.1186/cc5055.
4. Biswas SK, Lopez-Collazo E, (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30: 475-487 doi:10.1016/j.it.2009.07.009.
5. Watson DW, Kim YB, (1963) Modification of host responses to bacterial endotoxins. I. Specificity of pyrogenic tolerance and the role of hypersensitivity in pyrogenicity, lethality, and skin reactivity. J Exp Med 118: 425-446.
6. Heemann U, Szabo A, Hamar P, Müller V, Witzke O, et al. (2000) Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: possible connection to an interleukin-6-dependent pathway. Am J Pathol 156: 287-293 doi:10.1016/S0002-9440(10)64729-3.
7. Brown JM, Grosso MA, Terada LS, Whitman GJ, Banerjee A, et al. (1989) Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci USA 86: 2516-2520.
8. Godet C, Goujon J-M, Petit I, Lecron J-C, Hauet T, et al. (2006) Endotoxin tolerance enhances interleukin-10 renal expression and decreases ischemia-reperfusion renal injury in rats. Shock 25: 384-388 doi:10.1097/01.shk.0000209528.35743.54.
9. Friedrich I, Spillner J, Lu E-X, Barnscheidt M, Kuss O, et al. (2003) Induction of endotoxin tolerance improves lung function after warm ischemia in dogs. Am J Physiol Lung Cell Mol Physiol 284: L224-231 doi:10.1152/ajplung.00138.2002.
10. Ackermann M, Reuter M, Flohé S, Bahrami S, Redl H, et al. (2001) Cytokine synthesis in the liver of endotoxin-tolerant and normal rats during hemorrhagic shock. J Endotoxin Res 7: 105-112.
11. He W, Fong Y, Marano MA, Gershenwald JE, Yurt RW, et al. (1992) Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine responses. J Infect Dis 165: 859-864.
12. Cavaillon J-M, Adrie C, Fitting C, Adib-Conquy M, (2003) Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res 9: 101-107 doi:10.1179/096805103125001487.
13. Buttenschoen K, Kornmann M, Berger D, Leder G, Beger HG, et al. (2008) Endotoxemia and endotoxin tolerance in patients with ARDS. Langenbecks Arch Surg 393: 473-478 doi:10.1007/s00423-008-0317-3.
14. Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, et al. (2006) Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit Care Med 34: 2658-2665 doi:10.1097/01.CCM.0000240243.28129.36.
15. Rocksén D, Koch B, Sandström T, Bucht A, (2004) Lung effects during a generalized Shwartzman reaction and therapeutic intervention with dexamethasone or vitamin E. Shock 22: 482-490.
16. Berg DJ, Kühn R, Rajewsky K, Müller W, Menon S, et al. (1995) Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96: 2339-2347 doi:10.1172/JCI118290.
17. Greisman SE, Hornick RB, (1975) The nature of endotoxin tolerance. Trans Am Clin Clin Climatol Assoc 86: 43-50.
18. West MA, Koons A, (2008) Endotoxin tolerance in sepsis: concentration-dependent augmentation or inhibition of LPS-stimulated macrophage TNF secretion by LPS pretreatment. J Trauma 65: 893-898 discussion 898-900. doi:10.1097/TA.0b013e3181877fde.
19. Carlsson M, Lipcsey M, Larsson A, Tano E, Rubertsson S, et al. (2009) Inflammatory and circulatory effects of the reduction of endotoxin concentration in established porcine endotoxemic shock-a model of endotoxin elimination. Crit Care Med 37: 1031-e4 doi:10.1097/CCM.0b013e31819b5683.
20. Castegren M, Lipcsey M, Söderberg E, Skorup P, Eriksson M, et al. (2012) Differences in organ dysfunction in endotoxin-tolerant pigs under intensive care exposed to a second hit of endotoxin. Shock 37: 501-510 doi:10.1097/SHK.0b013e318249bb0d.
21. Riviere JE, Papich MG, Adams HR (2009) Veterinary pharmacology and therapeutics. Ames, IA: Wiley-Blackwell. 1500 p.
22. Lipcsey M, Larsson A, Eriksson MB, Sjölin J, (2008) Effect of the administration rate on the biological responses to a fixed dose of endotoxin in the anesthetized pig. Shock 29: 173-180 doi:10.1097/SHK.0b013e318067dfbc.
23. Schmidhammer R, Wassermann E, Germann P, Redl H, Ullrich R, (2006) Infusion of increasing doses of endotoxin induces progressive acute lung injury but prevents early pulmonary hypertension in pigs. Shock 25: 389-394 doi:10.1097/01.shk.0000209529.43367.00.
24. Lipcsey M, Larsson A, Eriksson MB, Sjölin J, (2006) Inflammatory, coagulatory and circulatory responses to logarithmic increases in the endotoxin dose in the anaesthetised pig. J Endotoxin Res 12: 99-112 doi:10.1179/096805106X89053.
25. Poli-de-Figueiredo LF, Garrido AG, Nakagawa N, Sannomiya P, (2008) Experimental models of sepsis and their clinical relevance. Shock 30 Suppl 1: 53-59 doi:10.1097/SHK.0b013e318181a343.
26. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377 doi:10.1056/NEJMoa010307.
27. Koff WC, Fann AV, Dunegan MA, Lachman LB, (1986) Catecholamine-induced suppression of interleukin-1 production. Lymphokine Res 5: 239-247.
28. Madera-Salcedo IK, Cruz SL, Gonzalez-Espinosa C, (2011) Morphine decreases early peritoneal innate immunity responses in Swiss-Webster and C57BL6/J mice through the inhibition of mast cell TNF-α release. J Neuroimmunol 232: 101-107 doi:10.1016/j.jneuroim.2010.10.017.
29. Chang Y, Chen T-L, Sheu J-R, Chen R-M, (2005) Suppressive effects of ketamine on macrophage functions. Toxicol Appl Pharmacol 204: 27-35 doi:10.1016/j.taap.2004.08.011.
30. Gao J, Zhao W-X, Xue F-S, Zhou L-J, Xu S, et al. (2010) Early administration of propofol protects against endotoxin-induced acute lung injury in rats by inhibiting the TGF-beta1-Smad2 dependent pathway. Inflamm Res 59: 491-500 doi:10.1007/s00011-009-0110-y.
31. Lovett EJ 3rd, Alderman J, Munster E, Lundy J, (1980) Suppressive effects of thiopental and halothane on specific arms of the immune response. J Surg Oncol 15: 327-334.
32. Draisma A, Pickkers P, Bouw MPWJM, van der Hoeven JG, (2009) Development of endotoxin tolerance in humans in vivo. Crit Care Med 37: 1261-1267 doi:10.1097/CCM.0b013e31819c3c67.
33. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, et al. (1995) Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med 181: 1887-1892.
34. Fu Y, Glaros T, Zhu M, Wang P, Wu Z, et al. (2012) Network topologies and dynamics leading to endotoxin tolerance and priming in innate immune cells. PLoS Comput Biol 8: e1002526 doi:10.1371/journal.pcbi.1002526.
35. Fujii E, Yoshioka T, Ishida H, Irie K, Muraki T, (2000) Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide. Br J Pharmacol 130: 90-94 doi:10.1038/sj.bjp.0703277.
36. Dias MB, Almeida MC, Carnio EC, Branco LGS, (2005) Role of nitric oxide in tolerance to lipopolysaccharide in mice. J Appl Physiol 98: 1322-1327 doi:10.1152/japplphysiol.01243.2004.
37. Wang W, Deng M, Liu X, Ai W, Tang Q, et al. (2011) TLR4 activation induces nontolerant inflammatory response in endothelial cells. Inflammation 34: 509-518 doi:10.1007/s10753-010-9258-4.
38. Protti A, Singer M, (2006) Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care 10: 228 doi:10.1186/cc5014.
39. Hollenberg SM, Cinel I, (2009) Bench-to-bedside review: nitric oxide in critical illness-update 2008. Crit Care 13: 218 doi:10.1186/cc7706.
40. Brozna JP, (1990) Shwartzman reaction. Semin Thromb Hemost 16: 326-332 doi:10.1055/s-2007-1002685.